Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

745

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2011

Conditions
NauseaVomiting
Interventions
DIETARY_SUPPLEMENT

ginger

Given orally

OTHER

placebo

Given orally

Trial Locations (19)

11030

CCOP - North Shore University Hospital, Manhassett

13057

CCOP - Hematology-Oncology Associates of Central New York, East Syracuse

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

36606

MBCCOP - Gulf Coast, Mobile

43215

CCOP - Columbus, Columbus

49503

CCOP - Grand Rapids, Grand Rapids

54449

CCOP - Marshfield Clinic Research Foundation, Marshfield

55416

CCOP - Metro-Minnesota, Saint Louis Park

62526

CCOP - Central Illinois, Decatur

64131

CCOP - Kansas City, Kansas City

89106

CCOP - Nevada Cancer Research Foundation, Las Vegas

96813

MBCCOP - Hawaii, Honolulu

97225

CCOP - Columbia River Oncology Program, Portland

60612-7323

MBCCOP - University of Illinois at Chicago, Chicago

67214-3882

CCOP - Wichita, Wichita

49007-3731

CCOP - Kalamazoo, Kalamazoo

27534-9479

CCOP - Southeast Cancer Control Consortium, Goldsboro

98405-0986

CCOP - Northwest, Tacoma

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gary Morrow

OTHER

NCT00040742 - Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer | Biotech Hunter | Biotech Hunter